WallStSmart
ALDX

Aldeyra The

NASDAQ: ALDX · HEALTHCARE · BIOTECHNOLOGY

$1.71
-7.39% today

Updated 2026-06-05

Market cap
$98.93M
P/E ratio
P/S ratio
EPS (TTM)
$-0.45
Dividend yield
52W range
$1 – $6
Volume
1.4M

WallStSmart proprietary scores

25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.5
Quality
C+
3.5
Profitability
D
5.0
Valuation
C+
2/9
Piotroski F-Score
Weak
-9.2
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$7.60
+344.44%
12-Month target
Intrinsic (DCF)
Margin of safety
1 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
+ Debt/equity 0.37x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -9.18 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-5.11M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-62.02M$-37.54M$-55.85M$-33.85M$-3.45M
EPS$-0.45
Free cash flow$-56.65M$-30.33M$-43.21M$-33.35M$-5.11M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
ALDX$98.93M254.33.55.05.5Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

Aldeyra The trades at $1.71. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -9.18, it sits in the distress.

Frequently asked questions

What is Aldeyra The's stock price?

Aldeyra The (ALDX) trades at $1.71.

Is Aldeyra The overvalued?

Aldeyra The carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Aldeyra The (ALDX)?

The 12-month analyst consensus target is $7.60, about 344.4% above the current $1.71. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Aldeyra The's Altman Z-Score is -9.18, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE
Beta1.15
50D MA$1.69
200D MA$4.21
Shares out0.06B
Float0.05B
Short ratio
Avg volume1.4M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years